Nephro Care India (NSE:NEPHROCARE) ROCE % : 21.17% (As of Sep. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Nephro Care India ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Nephro Care India's annualized ROCE % for the quarter that ended in Sep. 2024 was 21.17%.

Nephro Care India ROCE % Historical Data

The historical data trend for Nephro Care India's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nephro Care India ROCE % Chart

Nephro Care India Annual Data

Trend

Mar21

Mar22

Mar23

ROCE %

22.83

0.83

71.19

Nephro Care India Semi-Annual Data
	Mar21	Mar22	Mar23	Sep24
ROCE %	-	-	-	21.17

Nephro Care India ROCE % Calculation

Nephro Care India's annualized ROCE % for the fiscal year that ended in Mar. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Mar. 2023 )		(A: Mar. 2022 )		(A: Mar. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Mar. 2023 )		(A: Mar. 2022 )		(A: Mar. 2023 )
	=	28.02	/	( ( (46.293 - 16.477)	+	(83.111 - 34.206) )	/ 2 )
	=	28.02	/	( (29.816	+	48.905)	/ 2 )
	=	28.02	/	39.3605
	=	71.19 %

Nephro Care India's ROCE % of for the quarter that ended in Sep. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Sep. 2024 )		(Q: Mar. 2023 )		(Q: Sep. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Sep. 2024 )		(Q: Mar. 2023 )		(Q: Sep. 2024 )
	=	61.298	/	( ( (83.111 - 34.206)	+	(671.56 - 141.324) )	/ 2 )
	=	61.298	/	( ( 48.905	+	530.236 )	/ 2 )
	=	61.298	/	289.5705
	=	21.17 %

(1) Note: The EBIT data used here is two times the semi-annual (Sep. 2024) EBIT data.

Nephro Care India (NSE:NEPHROCARE) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Nephro Care India ROCE % Related Terms

Thank you for viewing the detailed overview of Nephro Care India's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Nephro Care India Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Nephro Care India Ltd (NSE:NEPHROCARE) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

c/o EFC India - Millenium City IT Park, 12th Floor, DN 62, DN Block, Sector V, Bidhannagar, Kolkata, WB, IND, 700091

Website

https://www.nephrocareindia.com

Nephro Care India Ltd is a Kolkata-based healthcare provider specializing in comprehensive medical services for renal patients. The company serves as a one-stop treatment center, offering a broad spectrum of clinical and lifestyle solutions, along with specialized treatments for renal insufficiency. Its holistic care framework addresses not only the medical and physiological aspects of treatment but also focuses on lifestyle and spiritual wellness, providing an integrated approach to patient care.

Nephro Care India Headlines

No Headlines